Copied and shared... *$NVDA | NVIDIA's Q3 FY2027 presentation reveals accelerating enterprise AI demand, nearly $20B in sequential Vera Rubin revenue growth and plans to deploy $227B in remaining share buybacks through FY2028.* • *AI Customer Breakdown:* Hyperscaler revenue rose 71% YoY to $60.1B, while AI cloud, industrial and enterprise revenue surged 195% to $47.5B. The latter contributed roughly 56% of Data Center's annual revenue increase, signaling demand growth beyond traditional hyperscalers. • *Vera Rubin Momentum:* NVIDIA says Vera Rubin added nearly $20B in revenue QoQ, making it the fastest product ramp in company history. Rubin NVL72 also delivered up to twice Blackwell Ultra's per-GPU performance in its MLPerf Training debut. • *Capacity Utilization:* NVIDIA says its deployed compute infrastructure remains fully utilized, supporting its argument that demand remains strong even as newer GPU generations enter production. • *Improving Product Mix:* Q3 adjusted gross margin increased 1.4 percentage points YoY to 74.9%, driven by a more favorable Blackwell Ultra product mix. GAAP gross margin also improved 1.4 points to 74.8%. • *Operating Leverage:* Adjusted operating expenses rose 52% YoY to $8.8B, significantly slower than revenue growth of 103%. Adjusted operating income consequently jumped 116% to $77.9B. • *Infrastructure Investment:* Capital expenditures for property, equipment and intangibles increased to $4.42B from $1.64B a year earlier, reflecting expanded investment in NVIDIA's operations and capacity. • *Buyback Timeline:* Free cash flow nearly doubled to $43.8B from $22.1B. NVIDIA plans to utilize its approximately $227B remaining share repurchase authorization through FY2028. • *Accounting Detail:* A $1.77B gain on equity securities helped lift GAAP EPS to $2.70, above adjusted EPS of $2.68. NVIDIA also clarified that its adjusted earnings now include stock-based compensation, with historical figures updated for comparability. • *Risk Disclosures:* NVIDIA explicitly identifies CEO succession, executive retention, regulatory investigations and litigation among the uncertainties that could affect future results.